Ally Financial Inc. Takes Position in Colgate-Palmolive Company $CL

Ally Financial Inc. acquired a new stake in Colgate-Palmolive Company (NYSE:CL) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 13,000 shares of the company’s stock, valued at approximately $1,027,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. CBIZ Investment Advisory Services LLC grew its position in Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after acquiring an additional 150 shares during the period. Triumph Capital Management grew its position in Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after acquiring an additional 127 shares during the period. Jessup Wealth Management Inc purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $26,000. Maseco LLP purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $27,000. Finally, Global Wealth Strategies & Associates grew its position in Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after acquiring an additional 300 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.0%

Shares of NYSE CL opened at $89.40 on Friday. The stock’s 50 day moving average price is $86.85 and its two-hundred day moving average price is $86.25. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock has a market capitalization of $71.54 billion, a P/E ratio of 34.79, a PEG ratio of 4.72 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. During the same quarter in the prior year, the firm posted $0.91 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 8.4% compared to the same quarter last year. On average, analysts anticipate that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Weiss Ratings raised Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. TD Cowen reaffirmed a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Barclays upped their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 5th. Finally, Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research report on Thursday. They issued a “market perform” rating and a $96.00 target price for the company. Twelve investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.